BIP
UTMD icon

Brandes Investment Partners’s Utah Medical Products UTMD Stock Holding History

Brandes Investment Partners’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.8M Buy
475,158
+25,879
+6% +$1.72M 0.23% 114
2026
Q1 		$27.9M Buy
449,279
+97,957
+28% +$6.17M 0.2% 117
2025
Q4 		$19.7M Buy
351,322
+13,392
+4% +$776K 0.15% 116
2025
Q3 		$21.3M Buy
337,930
+66,608
+25% +$3.94M 0.17% 109
2025
Q2 		$15.4M Buy
271,322
+29,073
+12% +$1.58M 0.14% 111
2025
Q1 		$13.6M Buy
242,249
+79,280
+49% +$4.75M 0.14% 110
2024
Q4 		$10M Buy
162,969
+24,604
+18% +$1.59M 0.11% 116
2024
Q3 		$9.26M Buy
138,365
+21,841
+19% +$1.48M 0.1% 113
2024
Q2 		$7.79M Buy
116,524
+46,427
+66% +$3.16M 0.1% 110
2024
Q1 		$4.98M Buy
70,097
+37,272
+114% +$2.8M 0.06% 115
2023
Q4 		$2.76M Buy
32,825
+5,746
+21% +$477K 0.04% 129
2023
Q3 		$2.33M Buy
27,079
+3,799
+16% +$351K 0.05% 123
2023
Q2 		$2.17M Buy
23,280
+1,775
+8% +$167K 0.04% 123
2023
Q1 		$2.04M Buy
+21,505
New +$1.98M 0.04% 124
2022
Q4 		– Sell
-7,858
Closed -$670K – 159
2022
Q3 		$670K Sell
7,858
-68
-0.9% -$6K 0.02% 143
2022
Q2 		$681K Buy
+7,926
New +$676K 0.02% 143
2021
Q4 		– Sell
-9,226
Closed -$857K – 170
2021
Q3 		$857K Sell
9,226
-453
-5% -$40K 0.02% 131
2021
Q2 		$823K Buy
9,679
+4,317
+81% +$374K 0.02% 129
2021
Q1 		$465K Buy
+5,362
New +$472K 0.01% 137
2019
Q3 		– Sell
-2,468
Closed -$236K – 149
2019
Q2 		$236K Buy
+2,468
New +$208K 0.01% 134
2017
Q4 		– Sell
-39,022
Closed -$2.87M – 167
2017
Q3 		$2.87M Sell
39,022
-108
-0.3% -$7.77K 0.06% 106
2017
Q2 		$2.83M Buy
+39,130
New +$2.58M 0.04% 105
2016
Q2 		– Sell
-9,570
Closed -$599K – 203
2016
Q1 		$599K Sell
9,570
-4,623
-33% -$273K 0.01% 131
2015
Q4 		$831K Buy
+14,193
New +$805K 0.01% 122

Other funds holding UTMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brandes Investment Partners's UTMD Position: Q2 2026 in Review

Brandes Investment Partners increased its Utah Medical Products (UTMD) stake by 5.8% in Q2 2026, buying an estimated $1.72M and bringing the position to 475,158 shares worth $32.8M. The position accounts for 0.23% of the portfolio, ranked #114.

Brandes Investment Partners first reported a position in UTMD in Q4 2015 and has held it in 24 quarters since. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Brandes Investment Partners held 475,158 shares of Utah Medical Products worth $32.8M as of Q2 2026.
  • Brandes Investment Partners bought 25,879 Utah Medical Products shares in Q2 2026, an estimated $1.72M.
  • Utah Medical Products made up 0.23% of Brandes Investment Partners's portfolio in Q2 2026, its #114 holding.
  • Brandes Investment Partners first reported a position in Utah Medical Products in Q4 2015 and has held it in 24 quarters since.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Brandes Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.